215 related articles for article (PubMed ID: 23466098)
1. Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients.
Schuck RN; Theken KN; Edin ML; Caughey M; Bass A; Ellis K; Tran B; Steele S; Simmons BP; Lih FB; Tomer KB; Wu MC; Hinderliter AL; Stouffer GA; Zeldin DC; Lee CR
Atherosclerosis; 2013 Apr; 227(2):442-8. PubMed ID: 23466098
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Theken KN; Schuck RN; Edin ML; Tran B; Ellis K; Bass A; Lih FB; Tomer KB; Poloyac SM; Wu MC; Hinderliter AL; Zeldin DC; Stouffer GA; Lee CR
Atherosclerosis; 2012 Jun; 222(2):530-6. PubMed ID: 22503544
[TBL] [Abstract][Full Text] [Related]
3. Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.
Theken KN; Deng Y; Schuck RN; Oni-Orisan A; Miller TM; Kannon MA; Poloyac SM; Lee CR
Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E500-9. PubMed ID: 22185841
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study.
Oni-Orisan A; Edin ML; Lee JA; Wells MA; Christensen ES; Vendrov KC; Lih FB; Tomer KB; Bai X; Taylor JM; Stouffer GA; Zeldin DC; Lee CR
J Lipid Res; 2016 Jan; 57(1):109-19. PubMed ID: 26555503
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
[TBL] [Abstract][Full Text] [Related]
6. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
7. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
8. Epoxyeicosatrienoic acid pathway in human health and diseases.
Bellien J; Joannides R
J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
10. Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism.
Theken KN; Deng Y; Kannon MA; Miller TM; Poloyac SM; Lee CR
Drug Metab Dispos; 2011 Jan; 39(1):22-9. PubMed ID: 20947618
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 eicosanoids and cerebral vascular function.
Imig JD; Simpkins AN; Renic M; Harder DR
Expert Rev Mol Med; 2011 Mar; 13():e7. PubMed ID: 21356152
[TBL] [Abstract][Full Text] [Related]
12. CYP Genetic Variants, CYP Metabolite Levels, and Neurologic Deterioration in Acute Ischemic Stroke in Chinese Population.
Yi X; Lin J; Wang C; Zhou Q
J Stroke Cerebrovasc Dis; 2017 May; 26(5):969-978. PubMed ID: 27916259
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.
Huang H; Al-Shabrawey M; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():45-53. PubMed ID: 26747234
[TBL] [Abstract][Full Text] [Related]
14. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
Nayeem MA; Geldenhuys WJ; Hanif A
Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450-derived eicosanoids and heart function.
Jamieson KL; Endo T; Darwesh AM; Samokhvalov V; Seubert JM
Pharmacol Ther; 2017 Nov; 179():47-83. PubMed ID: 28551025
[TBL] [Abstract][Full Text] [Related]
16. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
17. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice.
Hercule HC; Schunck WH; Gross V; Seringer J; Leung FP; Weldon SM; da Costa Goncalves ACh; Huang Y; Luft FC; Gollasch M
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):54-60. PubMed ID: 18927469
[TBL] [Abstract][Full Text] [Related]
18. CYP-derived eicosanoids: Implications for rheumatoid arthritis.
Hoxha M; Zappacosta B
Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106405. PubMed ID: 31838196
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450-dependent eicosanoid production and crosstalk.
Fleming I
Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
[TBL] [Abstract][Full Text] [Related]
20. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
